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INTRODUCTION
In the U.S., 18.5% of U.S. youth aged 2–19 years have obesity.1 Since 2003, the American 
Academy of Pediatrics has recommended measurement of weight and height at each 
preventive visit for all children and adolescents to screen for obesity; current guidelines 
apply to those aged ≥2 years.2–4
This study analyzed trends and differences by age in preventive visits of U.S. youth aged 2–
19 years to pediatricians and family medicine physicians in which weight and height were 
recorded between 2005 and 2016.
METHODS
The National Ambulatory Medical Care Survey is an annual, nationally representative 
survey of patient visits made to nonfederal, office-based physicians in the U.S., conducted 
by the National Center for Health Statistics. The response rate (the percentage of in-scope 
physicians for whom at least one-half of their expected number of visit records was 
completed) ranged from 32.7% in 2016 to 61.5% in 2005. Detailed information regarding 
the survey is available elsewhere (www.cdc.gov/nchs/ahcd/).
The unit of analysis was ambulatory care visits (number of visits rather than the number of 
people) and multiple visits for the same person could be represented in the data. Preventive 
visits were defined as any visit reported for general medical examination, well-baby 
examination, or physical examination required for school or employment to family practice 
physicians or pediatricians. Overall, 82.8% of the preventive visits were to pediatricians. 
Pregnant female patients were excluded from analysis.
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The percentage of preventive visits with recorded weight and height along with 95% CIs are 
reported. Because there are differences by age in obesity prevalence,1 trends by age (2–11 
and 12–19 years) were analyzed. Annual percentage point change and 95% CI were reported 
from the linear regression models. Differences between age groups were evaluated with two-
tailed t-tests using p<0.05 as the level of significance. Statistical analyses accounted for the 
complex survey design. Analyses were conducted in 2018 using SAS, version 9.4 and 
SUDAAN, version 11.0.
RESULTS
The overall percentage of preventive visits in which weight and height were recorded 
increased from 87.6% (95% CI=81.6%, 92.3%) in 2005 to 95.6% (95% CI=88.4%, 99.0%) 
in 2016 (p<0.001). Among children aged 2–11 years, the percentage increased from 86.9% 
(95% CI=79.5%, 92.4%) in 2005 to 96.5% (95% CI=88.1%, 99.5%) in 2016 (p=0.007). 
Among adolescents, the percentage increased from 89.0% (95% CI=81.0%, 94.4%) in 2005 
to 94.1% (95% CI=85.3%, 98.4%) in 2016 (p<0.001) (Table 1).
DISCUSSION
These results expand on earlier analyses5,6 with more recent data, a wider age range, and a 
focus on preventive visits to family practice physicians or pediatricians. Weight and height 
were recorded during almost all (95.6%) preventive visits in 2016, higher than the 87.6% in 
2005. However, it is unknown whether BMI was calculated from weight and height and 
obesity screening occurred during these preventive visits. Trends among visits to family 
practice physicians and pediatricians were similar and there was no consistent difference 
between the specialty groups. Small sample size precluded further subgroup analysis. Future 
data will determine whether these trends continue.
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